Comparative Performance of the Reverse Algorithm Using Architect Syphilis TP Versus the Traditional Algorithm Using Rapid Plasma Reagin in Florida’s Public Health Testing Population
0
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
In Florida, where syphilis is a reportable disease, the number of primary and secondary (P&S) syphilis cases has increased from 3,266 in 2008–2010 to 5,340 in 2013–2015, a 63% increase. The objective of this study was to compare the performance and sensitivity of the syphilis reverse algorithm with the traditional algorithm for detecting P&S (infectious) syphilis cases. Clinical specimens from individuals who self-referred for syphilis testing at public health clinics were processed using the traditional algorithm (non-treponemal rapid plasma reagin (RPR) test followed by a confirmatory treponemal (EIA) test) and then further tested with the Architect Syphilis TP (ASTP) immunoassay (Abbott Diagnostics, Chicago, IL, USA) or by RPR confirmation, if needed (reverse algorithm). Of 1,079 specimens, 59 were positive for syphilis. The sensitivity of the reverse algorithm was 98.3% (58/59) and of the traditional algorithm was 72.9% (43/59). Based on clinical evidence, of the 16 traditional algorithm-negative but reverse algorithm-positive cases, 68.8% (11/16) were classified as missed P&S infections (treatment naïve) and 31.2% (5/16) were classified as missed past syphilis (latent or infections with documented linkage to care). The reverse algorithm enables the detection of additional P&S syphilis cases missed by our current traditional algorithm.
Abstract
In Florida, where syphilis is a reportable disease, the number of primary and secondary (P&S) syphilis cases has increased from 3,266 in 2008–2010 to 5,340 in 2013–2015, a 63% increase. The objective of this study was to compare the performance and sensitivity of the syphilis reverse algorithm with the traditional algorithm for detecting P&S (infectious) syphilis cases. Clinical specimens from individuals who self-referred for syphilis testing at public health clinics were processed using the traditional algorithm (non-treponemal rapid plasma reagin (RPR) test followed by a confirmatory treponemal (EIA) test) and then further tested with the Architect Syphilis TP (ASTP) immunoassay (Abbott Diagnostics, Chicago, IL, USA) or by RPR confirmation, if needed (reverse algorithm). Of 1,079 specimens, 59 were positive for syphilis. The sensitivity of the reverse algorithm was 98.3% (58/59) and of the traditional algorithm was 72.9% (43/59). Based on clinical evidence, of the 16 traditional algorithm-negative but reverse algorithm-positive cases, 68.8% (11/16) were classified as missed P&S infections (treatment naïve) and 31.2% (5/16) were classified as missed past syphilis (latent or infections with documented linkage to care). The reverse algorithm enables the detection of additional P&S syphilis cases missed by our current traditional algorithm.
참고문헌 (11)
- "Florida CHARTS" (2018)[URL]
- "Suggested reporting language for syphilis serology" (2015)[URL]
- "Sexually transmitted diseases treatment guidelines" (2016)[URL]
- "Reverse sequence screening for syphilis" (2014)[URL]
- Tong ML, "Analysis of 3 algorithms for syphilis serodiagnosis and implications for clinical management", Clin Infect Dis, 58, pp.1116~1124 (2014)
- "Bureau of Communicable Diseases. 2016 Reportable syphilis cases" (2017)[URL]
- Mishra S, "The laboratory impact of changing syphilis screening from the rapid plasma reagin to a treponemal enzyme immunoassay : a case-study from the Greater Toronto Area", Sex Transm Dis, 38, pp.190~196 (2011)
- Morshed MG, "Recent trends in the serologic diagnosis of syphilis", Clin Vaccine Immunol, 22, pp.137~147 (2015)
- Harrell W Chesson, "Formulas for estimating the costs averted by sexually transmitted infection (STI) prevention programs in the United States", Cost Effectiveness and Resource Allocation, 6(1), pp.10~ (2008), Springer Science and Business Media LLC[DOI]
- "CDC. Fact sheet, reported STDs in the United States" (2018)[URL]
- "Syphilis and HIV: intersection of two epidemics" (2017)[URL]
